pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

8,982 catalysts · 3,126 8k filing · 1,811 grant · 1,000 device adverse event · 867 approval · 647 device 510k · 583 earnings

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-10: 0 catalysts2026-08-11: 97 catalysts2026-08-12: 19 catalysts2026-08-13: 19 catalysts2026-08-14: 4 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 1 catalyst2026-08-18: 2 catalysts2026-08-19: 2 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 1 catalyst2026-08-27: 1 catalyst2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 1 catalyst2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 2 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 2 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 1 catalyst2026-10-20: 2 catalysts2026-10-21: 2 catalysts2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 1 catalyst2026-10-27: 8 catalysts2026-10-28: 12 catalysts2026-10-29: 21 catalysts2026-10-30: 4 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts2026-11-02: 9 catalysts2026-11-03: 18 catalysts2026-11-04: 22 catalysts2026-11-05: 37 catalysts2026-11-06: 2 catalysts2026-11-07: 0 catalysts2026-11-08: 0 catalysts
view
agendamonth
sort
soonestlatesttypesponsoralpha
from 2026-02-02×clear all
type
  • 8k filing3,126
  • grant1,811
  • device adverse event1,000
  • approval867
  • device 510k647
  • earnings583
device pma
497
  • device recall202
  • phase 2 completion172
  • recall167
  • therapy area
    • Oncology148
    • Infectious Disease46
    • Cardiology37
    • Immunology35
    • Dermatology31
    • Pulmonology22
    • Women's Health19
    • Ophthalmology16
    • Pain15

    Week of Feb 2, 2026

    50
    ›Feb 2, 2026grant191d agoLOYOLA UNIVERSITY CHICAGO — Defining the mechanism of CNS inflammation induced by colitis

    AI grant. $423,500. PI: Edward M. Campbell

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoOHIO STATE UNIVERSITY — Clearance of gut derived LPS by hepatic Stabilin receptors: Mechanisms and Im...

    AI grant. $758,645. PI: Latha Prabha Ganesan

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIVERSITY OF WISCONSIN-MADISON — Defining the role of YeiH in Salmonella pathogenesis

    AI grant. $427,625. PI: Johanna Rebecca Elfenbein

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoTERASAKI INSTITUTE FOR BIOMEDICAL INNOVATION — Vascularized porcine liver on-a-chip modeling human xenoimmunity

    AI grant. $492,250. PI: Angeles Baquerizo

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoWASHINGTON UNIVERSITY — Differentiation of uterine tissue-resident natural killer cells

    HD grant. $36,673. PI: Josselyn Del Carmen Barahona

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoSTANFORD UNIVERSITY — Development and assessment of new highly specific PET tracers for imaging inn...Stanford University

    AG grant. $50,114. PI: Renesmee Chenting Kuo

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON — Spatial analysis of gene expression in fungal infections

    AI grant. $429,000. PI: Jose Christian Perez

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoTUFTS UNIVERSITY BOSTON — Shigella regulation of GSDMD palmitoylation in epithelial cells

    AI grant. $453,750. PI: CAMMIE LESSER

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoJOHNS HOPKINS UNIVERSITY — Identifying intervention opportunities in the continuum of cognitive impairme...Johns Hopkins University

    MH grant. $50,114. PI: Madeline M Brooks

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIV OF NORTH CAROLINA CHAPEL HILL — Evaluating Nurse Demands and Resources with Virtual Nursing to Mitigate Burnout

    NR grant. $668,153. PI: Saif Khairat

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIV OF MARYLAND, COLLEGE PARK — Characterizing NLRP11 Activation by Mycobacteria to Enhance Innate Immune Res...

    AI grant. $421,720. PI: VOLKER BRIKEN

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoDARTMOUTH COLLEGE — Aspergillus fumigatus persists within alveolar macrophages to drive chronic a...

    AI grant. $630,677. PI: JOSHUA J OBAR

    full page →nih reporter ↗
    ›Feb 2, 2026grant191d agoUNIVERSITY OF GEORGIA — Immunity induced by cryptococcal morphological strains in CD4+ T cell-deficie...

    AI grant. $400,932. PI: Xiaorong Lin

    full page →nih reporter ↗
    ›Feb 3, 2026approval190d agoATELVIA (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET, DELAYED RELEASE. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoRECLAST (ZOLEDRONIC ACID) — FDA approvalZOLEDRONIC ACID

    Sponsor: SANDOZ. Form: INJECTABLE. Route: INTRAVENOUS

    full page →ZOLEDRONIC ACID →fda approvals ↗
    ›Feb 3, 2026approval190d agoDYNA-HEX 4 (CHLORHEXIDINE GLUCONATE) — FDA approvalCoorg Instituite of Dental Sciences

    Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: AVET LIFESCIENCES. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoFOSAMAX (ALENDRONATE SODIUM) — FDA approvalALENDRONATE SODIUM

    Sponsor: ORGANON. Form: TABLET. Route: ORAL

    full page →ALENDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: SUN PHARM. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: SUN PHARM. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

    Sponsor: HIKMA. Form: SOLUTION. Route: ORAL

    full page →ALENDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoPREGABALIN — FDA approvalPREGABALIN

    Sponsor: MSN. Form: TABLET, EXTENDED RELEASE. Route: ORAL

    full page →PREGABALIN →fda approvals ↗
    ›Feb 3, 2026approval190d agoSELENIOUS ACID — FDA approvalRK Pharma Inc

    Sponsor: KINDOS. Form: SOLUTION. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoVYKOURA (LEUCOVORIN CALCIUM) — FDA approvalLEUCOVORIN CALCIUM

    Sponsor: AVYXA HOLDINGS. Form: SOLUTION. Route: INTRAMUSCULAR, INTRAVENOUS

    full page →LEUCOVORIN CALCIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX INC. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: AUROBINDO PHARMA. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoDYNA-HEX 2 (CHLORHEXIDINE GLUCONATE) — FDA approvalCoorg Instituite of Dental Sciences

    Sponsor: XTTRIUM. Form: SOLUTION. Route: TOPICAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoALENDRONATE SODIUM — FDA approvalALENDRONATE SODIUM

    Sponsor: NOVITIUM PHARMA. Form: SOLUTION. Route: ORAL

    full page →ALENDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: ACCORD HLTHCARE. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: MACLEODS PHARMS LTD. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: PHARMOBEDIENT. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: SUN PHARM INDUSTRIES. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: DR REDDYS LABS LTD. Form: TABLET. Route: ORAL

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: ORBION PHARMS. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: PHARMOBEDIENT. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: WATSON LABS TEVA. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: EUGIA PHARMA. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoBINOSTO (ALENDRONATE SODIUM) — FDA approvalOrganon & Co.

    Sponsor: RADIUS. Form: TABLET, EFFERVESCENT. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalIBANDRONATE SODIUM

    Sponsor: APOTEX. Form: INJECTABLE. Route: INTRAVENOUS

    full page →IBANDRONATE SODIUM →fda approvals ↗
    ›Feb 3, 2026approval190d agoSTIVARGA (REGORAFENIB) — FDA approvalBayer AG

    Sponsor: BAYER HLTHCARE. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoDOXORUBICIN HYDROCHLORIDE — FDA approvalBAXTER INTERNATIONAL INC

    Sponsor: QILU PHARM HAINAN. Form: INJECTABLE, LIPOSOMAL. Route: INJECTION

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoACTONEL (RISEDRONATE SODIUM) — FDA approvalAllergan Finance LLC

    Sponsor: APIL. Form: TABLET. Route: ORAL

    full page →fda approvals ↗
    ›Feb 3, 2026approval190d agoFOSAMAX PLUS D (ALENDRONATE SODIUM) — FDA approval(alendronate sodium + cholecalciferol)

    Sponsor: ORGANON LLC. Form: TABLET. Route: ORAL

    full page →(alendronate sodium + cholecalciferol) →fda approvals ↗
    ›Feb 3, 2026approval190d agoIBANDRONATE SODIUM — FDA approvalDR REDDYS LABORATORIES LTD

    Sponsor: NANG KUANG PHARM CO. Form: INJECTABLE. Route: INTRAVENOUS

    full page →fda approvals ↗
    ›Feb 3, 2026device 510k190d agoApplied Medical Technology, Inc. — Explant Express (510k cleared)

    Product code: QVS. Advisory committee: General, Plastic Surgery. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoDror Orthodesign , Ltd. — ZSmile System (510k cleared)Dror Ortho-Design, Inc.

    Product code: NXC. Advisory committee: Dental. Type: Special

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoStryker GmbH — T2 Alpha Femur Retrograde Nailing System; Pangea Femur Reconstruction System (510k cleared)STRYKER CORP

    Product code: HSB. Advisory committee: Orthopedic. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoNingbo Runyes Medical Instrument Co., Ltd. — Diagnostic X-Ray Equipment Model POCT22 (510k cleared)

    Product code: EHD. Advisory committee: Dental. Type: Traditional

    full page →fda device 510k ↗
    ›Feb 3, 2026device 510k190d agoCircadia Health, Inc. — The Circadia C300 System (C300) (510k cleared)

    Product code: DRT. Advisory committee: Cardiovascular. Type: Traditional

    full page →fda device 510k ↗
    ← prev
    page 2 of 180
    next →
    $RDY12.45+2.43%
    $RDY12.45+2.43%
    $RDY12.45+2.43%
    $RDY12.45+2.43%
    $OGN13.65+0.22%
    $RDY12.45+2.43%
    $RDY12.45+2.43%
    $RDY12.45+2.43%
    $RDY12.45+2.43%
    $OGN13.65+0.22%
    $BAX27.61-0.61%
    $OGN13.65+0.22%
    $RDY12.45+2.43%
    $RDY12.45+2.43%
    $DROR0.00500.00%
    $SYK347.77+0.57%